🔗 Share this article TikTok Influencers Driving Parallel Trade for Unlicensed Slimming Drug A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings. Investigational Drug Gaining Popularity Via Social Media Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes. Active Trade on Social Networks Additionally, a robust trade exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions. Learning About Retatrutide This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic. Healthcare Professionals Voice Concerns However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source. Some professionals said the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro. Regulatory Status and Enforcement Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison. Platform Response and Content Elimination According to TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures. Digital Trading Activities Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at home. After moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage. Item Details and Costs Within these groups, messages display black plastic packages with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”. Service Oversight and Security Actions A representative for Telegram said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Medical Expert Warnings “People are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said. Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.” Producer Position A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially serious health risks”.